Groove Botanicals, Inc.
GRVE · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | -0.07 | 0.60 | 0.24 |
| FCF Yield | -30.41% | -2.95% | -2.40% | -2.84% |
| EV / EBITDA | 0.00 | -11.04 | -202.64 | 0.00 |
| Quality | ||||
| ROIC | 0.00% | 35.05% | 50.39% | 140.46% |
| Gross Margin | 0.00% | 0.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 0.82 | 0.43 | 0.96 | 0.25 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -20.35% | 16.95% |
| Free Cash Flow Growth | -23.71% | 24.75% | -58.29% | 46.69% |
| Safety | ||||
| Net Debt / EBITDA | 0.00 | 0.01 | -3.53 | 0.00 |
| Interest Coverage | 0.00 | -39.49 | -1.82 | -2.07 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 11.38 |